Reuters logo
BRIEF-FDA permits marketing of mobile medical application for substance use disorder‍​
September 14, 2017 / 2:50 PM / a month ago

BRIEF-FDA permits marketing of mobile medical application for substance use disorder‍​

Sept 14 (Reuters) - U.S. Food and Drug Administration:

* FDA permits marketing of mobile medical application for substance use disorder‍​

* Says permitted marketing of the reset device to Pear Therapeutics

* Says clinical trial did not demonstrate effectiveness of using the Reset device in patients reporting opioids as their substance of abuse​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below